Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Shaji Sebastian and Timothy McDonald.
Shaji Sebastian
Connection Strength
0.178
Timothy McDonald
  1. Adalimumab and infliximab impair SARS-CoV-2 antibody responses: results from a therapeutic drug monitoring study in 11422 biologic-treated patients. J Crohns Colitis. 2021 Sep 02.
    View in: PubMed
    Score: 0.060
  2. Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD. Gut. 2021 10; 70(10):1884-1893.
    View in: PubMed
    Score: 0.059
  3. Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. Gut. 2021 05; 70(5):865-875.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.